Martin A. Mattingly

Filings by Martin A. Mattingly span 2 companies, the busiest being Achieve Life Sciences, Inc. and Tracon Pharmaceuticals, Inc. Between 1 June 2012 and 1 June 2016, the trades on record add up to 6 filings.

No open-market sale appears; the market trades are 1 purchase worth €10k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 4 option exercises.

The latest filing, published on 2 June 2016, reports a share grant in Tracon Pharmaceuticals, Inc. The clock since the last published purchase (4 June 2012) now reads 5,271 days. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.